Onconetix, Inc.
ONCO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | 185.1% | 4.8% | -85.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $1 |
| % Margin | 88.6% | 66.2% | 45.1% | 92.7% |
| R&D Expenses | -$0 | -$0 | $0 | -$0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $2 | $2 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $1 | $11 | $27 |
| Operating Expenses | $2 | $2 | $13 | $30 |
| Operating Income | -$2 | -$2 | -$13 | -$29 |
| % Margin | -681.5% | -1,817.4% | -12,369.2% | -4,093.7% |
| Other Income/Exp. Net | -$7 | -$0 | $4 | -$1 |
| Pre-Tax Income | -$9 | -$2 | -$9 | -$30 |
| Tax Expense | $0 | $0 | $0 | -$1 |
| Net Income | -$9 | -$2 | -$9 | -$29 |
| % Margin | -2,892.7% | -2,227.8% | -8,408.8% | -4,134.7% |
| EPS | -6.25 | -4.76 | -1,802 | -17.38 |
| % Growth | -31.3% | 99.7% | -10,268.2% | – |
| EPS Diluted | -6.25 | -4.76 | -1,802 | -17.38 |
| Weighted Avg Shares Out | 1 | 1 | 0 | 0 |
| Weighted Avg Shares Out Dil | 1 | 1 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$8 | -$2 | -$8 | -$30 |
| % Margin | -2,792.8% | -2,014.8% | -8,184.1% | -4,212% |